Maria Kousi, PhD
About Maria Kousi, PhD
Maria Kousi, PhD, is a research scientist at the Broad Institute of MIT and Harvard and a senior associate at Third Rock Ventures, with a focus on precision medicine for neurodevelopmental and neurodegenerative diseases. She has an extensive academic background, including a PhD in Genetics and numerous publications in the field.
Work at Broad Institute
Maria Kousi has been a Research Scientist at the Broad Institute of MIT and Harvard since 2018. In this role, she focuses on advancing research in human genetics and neurodegenerative disorders. Her work contributes to the institute's mission of transforming medicine through genomics and innovative research methodologies.
Current Role at Third Rock Ventures
Since 2020, Maria Kousi has served as a Senior Associate at Third Rock Ventures in Boston, Massachusetts. In this position, she leverages her scientific expertise to support the development of biotechnology companies focused on innovative therapies and drug discovery.
Educational Background
Maria Kousi holds a Doctor of Philosophy (Ph.D.) in Genetics of childhood onset epilepsies from the University of Helsinki, where she studied from 2008 to 2012. She also earned a Master's Degree in Genetics of human familial epilepsies from the same institution. Additionally, she completed her postdoctoral fellowship at Duke University, focusing on Human/Medical Genetics and Molecular Neuroscience from 2012 to 2015.
Research Experience
Maria Kousi has extensive research experience, having worked as a Senior Research Associate at Duke University and as a Research Scientist at Harvard University. She also contributed to research at the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) from 2018 to 2020. Her research spans various aspects of genetics, computational biology, and neurodegenerative diseases.
Publications and Contributions
Maria Kousi has authored 27 peer-reviewed publications and three book chapters. Her research contributions focus on the implementation of genetics and computational biology to understand genetic diseases. She has also delivered numerous presentations at international conferences, sharing her findings with the scientific community.